Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

NCT02677597 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Cisplatin Combined With S-1
DRUG: Cisplatin Combined With Paclitaxel

Sponsor

Fudan University